INTENSITY THERAPEUTICS INC
For the period ended Dec 31, 2024. Filed Mar 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 13, 2025
INTS$3.15+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8.
INDEX TO FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB #274) | |
|---|---|
| Financial Statements | |
| Balance sheets as of December 31, 2024 and 2023 | F-3 |
| Statements of operations for the years ended December 31, 2024 and 2023 | F-4 |
| Statements of changes in redeemable convertible preferred stock and stockholders’ equity (deficiency) for the years ended December 31, 2024 and 2023 | F-5 |
| Statements of cash flows for the years ended December 31, 2024 and 2023 | F-6 |
| Notes to December 31, 2024 and 2023 financial statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.